Sinopharm Group Co Ltd (1099.HK)
Company Info
Highlights
HK$57.42B
7.57
2.31
HK$16.02 - HK$23.65
HK$22.62
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Sinopharm Group Co Ltd (1099.HK) returned -14.22% year-to-date (YTD) and -10.54% over the past 12 months. Over the past 10 years, 1099.HK returned -3.82% annually, underperforming the S&P 500 benchmark at 10.46%.
1099.HK
-14.22%
3.14%
-9.14%
-10.54%
1.51%
-3.82%
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 1099.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -4.20% | -4.72% | -7.87% | 1.66% | 0.33% | -14.22% | |||||||
| 2024 | 0.49% | 6.81% | -8.66% | -1.05% | 6.86% | 2.31% | -11.52% | -0.98% | 14.41% | -7.02% | 4.96% | 5.67% | 9.64% |
| 2023 | -3.13% | 9.26% | 13.10% | 16.84% | -7.57% | -1.05% | -0.20% | -6.95% | -0.22% | -17.62% | 3.64% | 5.52% | 6.78% |
| 2022 | 2.48% | 8.63% | -5.30% | 1.57% | 7.16% | 2.35% | -5.36% | -2.89% | -9.95% | -4.96% | 23.26% | 7.59% | 22.50% |
| 2021 | 0.42% | -4.12% | 3.63% | 28.06% | 9.54% | -9.32% | -11.69% | -2.06% | 1.60% | -8.57% | -8.73% | 0.12% | -6.81% |
| 2020 | -10.37% | -5.69% | -27.48% | 20.41% | -9.24% | 7.69% | -6.96% | 3.36% | -14.78% | 8.98% | 8.13% | -1.57% | -31.41% |
| 2019 | 6.53% | -0.43% | -6.30% | -5.81% | -4.38% | -6.62% | 8.86% | -2.91% | -13.40% | 14.66% | -8.17% | 10.06% | -11.35% |
| 2018 | 2.22% | -0.00% | 13.75% | -15.78% | 5.29% | -9.47% | 7.62% | 17.62% | -1.92% | -1.31% | 1.98% | -14.66% | -0.45% |
| 2017 | 11.42% | 0.84% | 0.42% | -3.19% | 2.01% | -0.84% | -5.71% | 7.94% | -2.69% | 1.45% | -12.03% | 10.10% | 7.52% |
| 2016 | -12.22% | 4.03% | 23.42% | -4.99% | 8.11% | 4.03% | 1.62% | 5.86% | -6.29% | 1.34% | -4.11% | -11.74% | 4.12% |
| 2015 | 3.28% | -4.23% | 16.57% | 16.59% | 0.27% | -5.89% | -13.50% | -1.51% | -7.67% | 18.45% | 1.40% | -4.45% | 14.52% |
| 2014 | -1.57% | -1.60% | -1.39% | -4.00% | 3.19% | 3.51% | 6.53% | 18.38% | 4.99% | 6.69% | -4.62% | -5.02% | 25.32% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1099.HK is 34, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Sinopharm Group Co Ltd (1099.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Sinopharm Group Co Ltd provided a 5.20% dividend yield over the last twelve months, with an annual payout of HK$0.96 per share. The company has been increasing its dividends for 4 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.96 | HK$0.96 | HK$0.90 | HK$0.87 | HK$0.84 | HK$0.65 | HK$0.67 | HK$0.69 | HK$0.57 | HK$0.48 | HK$0.39 | HK$0.33 |
Dividend yield | 5.20% | 4.46% | 4.40% | 4.40% | 4.95% | 3.46% | 2.36% | 2.09% | 1.69% | 1.51% | 1.26% | 1.19% |
Monthly Dividends
The table displays the monthly dividend distributions for Sinopharm Group Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.96 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.96 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.90 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.90 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.87 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.87 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.84 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.84 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.65 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.65 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.67 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.67 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.69 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.69 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.57 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.57 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.48 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.48 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.39 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.39 |
| 2014 | HK$0.33 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.33 |
Dividend Yield & Payout
Dividend Yield
Sinopharm Group Co Ltd has a dividend yield of 5.20%, which is quite average when compared to the overall market.
Payout Ratio
Sinopharm Group Co Ltd has a payout ratio of 39.37%, which is quite average when compared to the overall market. This suggests that Sinopharm Group Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Sinopharm Group Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sinopharm Group Co Ltd was 64.95%, occurring on Mar 19, 2020. The portfolio has not yet recovered.
The current Sinopharm Group Co Ltd drawdown is 47.23%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -64.95% | Apr 6, 2018 | 483 | Mar 19, 2020 | — | — | — |
| -56.3% | Apr 8, 2010 | 345 | Aug 24, 2011 | 892 | Apr 13, 2015 | 1237 |
| -34.8% | May 27, 2015 | 63 | Aug 24, 2015 | 234 | Aug 8, 2016 | 297 |
| -27.32% | Aug 15, 2016 | 327 | Dec 7, 2017 | 76 | Apr 3, 2018 | 403 |
| -15.61% | Apr 14, 2015 | 17 | May 7, 2015 | 12 | May 26, 2015 | 29 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Sinopharm Group Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Sinopharm Group Co Ltd, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -40.4%.
Valuation
The Valuation section provides an overview of how Sinopharm Group Co Ltd is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 1099.HK, comparing it with other companies in the Medical Distribution industry. Currently, 1099.HK has a P/E ratio of 7.6. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 1099.HK compared to other companies in the Medical Distribution industry. 1099.HK currently has a PEG ratio of 2.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 1099.HK relative to other companies in the Medical Distribution industry. Currently, 1099.HK has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 1099.HK in comparison with other companies in the Medical Distribution industry. Currently, 1099.HK has a P/B value of 0.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |